Silver Rock Financial’s CERo Therapeutics CERO Stock Holding History
Bought
Maintained
Sold
Other funds holding CERO
MC
PC
MTCM
PAMP
KL
WRBC
SCM
AA
BFM
Silver Rock Financial's CERO Position: Q1 2023 in Review
Silver Rock Financial sold out of CERo Therapeutics (CERO) in Q1 2023, closing a stake of 23 shares — an estimated $475K sold.
Silver Rock Financial first reported a position in CERO in Q4 2022 and held it in 1 quarter. The position peaked at $475K in Q4 2022. 15 funds tracked by Wall St. Rank hold CERO as of Q1 2023.
- Silver Rock Financial reported no remaining CERo Therapeutics position as of Q1 2023 after selling out during the quarter.
- Silver Rock Financial sold 23 CERo Therapeutics shares in Q1 2023, an estimated $475K.
- Silver Rock Financial first reported a position in CERo Therapeutics in Q4 2022 and held it in 1 quarter.
- Silver Rock Financial's CERo Therapeutics position peaked at $475K in Q4 2022.
- 15 funds tracked by Wall St. Rank held CERo Therapeutics as of Q1 2023.
Based on Silver Rock Financial's 13F filing for Q1 2023, filed 15 May 2023.